KRT5 and neoplasm: This was supported molecularly by stratified expression of basal urothelial markers; for example, KRT5 expression and proliferation limited to the basal and suprabasal layers, and high tumor‐cell expression of FGFR3 in all cell layers (Fig. 3A).